Repositorio Dspace

Cytologic and histologic features of COVID-19 post-vaccination lymphadenopathy

Mostrar el registro sencillo del ítem

dc.contributor.author García-Molina, Francisco
dc.contributor.author Cegarra-Navarro, María-Francisca
dc.contributor.author Andrade-Gonzales, Renzo-Javier
dc.contributor.author Martínez-Diaz, Francisco
dc.date.accessioned 2025-11-21T08:43:54Z
dc.date.available 2025-11-21T08:43:54Z
dc.date.issued 2021-12-06
dc.identifier.citation García-Molina F, Cegarra-Navarro MF, Andrade-Gonzales RJ, Martinez-Díaz F. Cytologic and histologic features of COVID-19 post-vaccination lymphadenopathy. Cytojournal. 6 de diciembre de 2021;18:34.
dc.identifier.issn 0974-5963
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21912
dc.description.abstract In this study, we present six cases of axillary or supraclavicular lymphadenopathies in the days following to the Pfizer-BioNTech vaccine's first dose and its study for fine-needle aspiration cytology (two patients), biopsy with a gross needle (two patients), and the evolution of two other patients. Cytological smears and histological sections reveal reactive nodes, predominantly T, CD8, and the presence of atypia with striking mitosis. Differential diagnosis with viral lymphadenopathies and lymphoma is important, so the clinical correlation, in a vaccination context, sudden appearance, and progressive decrease in days of the adenopathy, is essential. In this article, we have studied the cytohistological manifestations of post-Pfizer-BioNTech vaccination lymphadenopathy and discussed its differential diagnosis.
dc.language.iso eng
dc.publisher SCIENTIFIC SCHOLAR LLC
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/  *
dc.title Cytologic and histologic features of COVID-19 post-vaccination lymphadenopathy
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 35126612
dc.relation.publisherversion https://cytojournal.com/cytologic-and-histologic-features-of-covid-19-post-vaccination-lymphadenopathy/
dc.identifier.doi 10.25259/Cytojournal_21_2021
dc.journal.title Cytojournal
dc.identifier.essn 1742-6413


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta